Ala Yaromina received a master’s in Radiation Biology from UCL Cancer Institute in 2003 and a PhD in Radiation Biology and Experimental Radiotherapy from Dresden University of Technology in 2007. She continued her research as a postdoctoral fellow in the Laboratory of Experimental Radiotherapy at the Medical Faculty at Dresden University of Technology, focusing on molecular imaging and prognostic/predictive biomarkers. In 2012, she joined the Department of Radiotherapy at Maastricht University, the Netherlands. She is now a Senior Research Scientist in the Department of Precision Medicine at Maastricht University. Her main research interests are non-uniform tumor irradiation, hypoxia-activated prodrugs, and immune-oncology.